BARBARA L CONNER ANDERSEN

Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy BURLINGAME, CA NPI 1003928243

General Payments — all program years on this page

$342.22

  • Category: General Payments
  • Program years: PY2018
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $342.22 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $342.2221

By paying entity

Latest program year (PY2018) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $128.2610
Acerta Pharma LLC $69.604
Genentech USA, Inc. $68.243
NOVARTIS PHARMACEUTICALS CORPORATION $24.531
PFIZER INC. $21.431
GENZYME CORPORATION $19.241
Kaleo, Inc. $10.921

By program year

Program yearAmountRecords
2018 $342.2221

Records — PY2018 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
559834555 AstraZeneca Pharmaceuticals LP $22.24 05/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560156087 AstraZeneca Pharmaceuticals LP $13.89 05/11/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
561621324 AstraZeneca Pharmaceuticals LP $13.39 01/04/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
562424477 AstraZeneca Pharmaceuticals LP $20.08 03/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
573039075 Kaleo, Inc. $10.92 05/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594072517 GlaxoSmithKline, LLC. $20.42 03/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594213931 GlaxoSmithKline, LLC. $16.32 04/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594299571 GlaxoSmithKline, LLC. $15.07 05/04/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594430417 GlaxoSmithKline, LLC. $3.50 05/04/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594768767 GlaxoSmithKline, LLC. $20.47 05/24/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594768821 GlaxoSmithKline, LLC. $3.91 05/24/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594981156 GlaxoSmithKline, LLC. $23.75 01/16/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
595063587 GlaxoSmithKline, LLC. $0.68 06/21/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
595063599 GlaxoSmithKline, LLC. $6.73 06/21/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
595201775 GlaxoSmithKline, LLC. $17.41 06/22/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
601893821 GENZYME CORPORATION $19.24 01/18/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602191999 Genentech USA, Inc. $19.97 01/29/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602192003 Genentech USA, Inc. $23.56 03/05/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602238628 Genentech USA, Inc. $24.71 04/27/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
607976519 Novartis Pharmaceuticals Corporation $24.53 06/15/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610807103 PFIZER INC. $21.43 04/23/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.